METHODS FOR TREATMENT OF CORONARY HEART DISEASE EVENTS BASED ON LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ACTIVITY
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Nov 13, 2014
filing date -
Jun 10, 2014
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Methods of treating coronary heart disease (CHD) events by measuring Lp-PLA2 activity are described herein. Described herein are methods that compare Lp-PLA2 activity levels to a binary cut point to guide clinical diagnosis and treatment of CHD. The methods described herein provide robust treatment of patients regardless of race or gender, and may allow the simplification of complex treatment decisions and enhance patient care.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully